Understanding Your Laboratory Test: What It Is, Why It Is Done, and What Your Results Mean

This is a laboratory test performed on a sample from your body, most often blood, urine, or another body fluid, that helps your healthcare provider evaluate how well certain organs are working, screen for disease, or monitor a condition you already have.

The Cerebrospinal Fluid (CSF) Lyme Disease IgM Immunoblot test is a specialized laboratory test that detects IgM antibodies specifically targeting Borrelia burgdorferi, the bacterium that causes Lyme disease, in the cerebrospinal fluid. The immunoblot technique (also called Western blot) identifies specific protein bands (antigens) of the bacteria, creating a characteristic pattern that helps confirm whether the patient has been exposed to the Lyme disease bacterium and if the infection has affected the nervous system.

Your provider may order this test to look for signs of infection, inflammation, or other health problems, to confirm or rule out a diagnosis, to check how well a treatment is working, or to include it as part of a routine checkup even when you feel well.

This test is performed when a patient has symptoms suggesting neurological involvement from Lyme disease, such as facial palsy, meningitis, radiculoneuritis, or encephalopathy, especially if they have a history of possible tick exposure or live in an area where Lyme disease is common. It helps differentiate between localized Lyme disease and neuroborreliosis (Lyme disease affecting the central nervous system). The test may also be used to monitor treatment response in patients with confirmed neurological Lyme disease.

The sample is usually collected by drawing a small amount of blood from a vein in your arm with a thin needle, although some tests use a urine sample, a throat or nasal swab, or a finger stick instead, and the collection process typically takes only a few minutes.

The test requires a cerebrospinal fluid sample, which is collected through a procedure called lumbar puncture (spinal tap). During this procedure, a healthcare provider inserts a thin needle between the vertebrae in the lower back to withdraw CSF from the spinal canal. The procedure is performed under sterile conditions, and the patient may need to lie flat for a period afterward. The CSF sample is then sent to a laboratory for immunoblot analysis.

Your results are compared with established reference ranges, and values that fall within the normal range generally suggest no abnormality, while values that are too high or too low may point to a condition that requires further testing or follow-up with your healthcare provider.

Results are reported as a band pattern showing which bacterial proteins (antigens) the patient's IgM antibodies have reacted with. A positive result (reactive band pattern) indicates that IgM antibodies against Borrelia burgdorferi have been detected in the CSF, suggesting neurological involvement. The specific combination of bands is interpreted according to standardized criteria. A negative result suggests no evidence of Borrelia infection in the central nervous system, though false negatives can occur early in infection or if the patient has been treated with antibiotics before testing.

The risks are usually minor and may include brief pain, bruising, or bleeding at the needle site, and rarely lightheadedness or infection; results can also be affected by medications, diet, timing, and laboratory variation, so an abnormal value does not always mean you are ill and a normal value does not always rule out disease.

The main risks are related to the lumbar puncture procedure, including headache, back pain, bleeding, or rare infection. Test limitations include: (1) IgM antibodies typically appear early in infection, so the test may be negative if testing is done too soon after exposure; (2) prior antibiotic treatment can cause false-negative results; (3) the test is specific for Borrelia burgdorferi and may not detect other Borrelia species that can cause similar diseases; (4) cross-reactivity with other conditions can occasionally cause false-positive results, so results should always be interpreted in clinical context.